Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

DARE holding history

Dare Bioscience, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DARE overviewAll 13F holders of DAREFull Q2 2026 holdings

Shares (Q2 2026)
6,810
Value
$14.4K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of DARE by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20266,810$14.4K<0.1%−36,553−84.3%ReducedHolders
Q1 202643,363$78.9K<0.1%+22,448+107.3%AddedHolders
Q4 202520,915$40.4K<0.1%−1,706−7.5%ReducedHolders
Q3 202522,621$47.5K<0.1%+7,613+50.7%AddedHolders
Q2 202515,008$35.9K<0.1%−7,083−32.1%ReducedHolders
Q1 202522,091$63.8K<0.1%−10,302−31.8%ReducedHolders
Q4 202432,393$101.1K<0.1%+31,508+3,560.2%AddedHolders
Q3 2024885$2.87K<0.1%−7,366−89.3%ReducedConverted for a 1-for-12 splitHolders
Q2 202499,016$33.3K<0.1%+98,516+19,703.2%AddedHolders
Q1 2024500$245<0.1%−8,100−94.2%ReducedHolders
Q4 20238,600$2.66K<0.1%+8,100+1,620.0%AddedHolders
Q3 2023500$231<0.1%00.0%UnchangedHolders
Q2 2023500$455<0.1%00.0%UnchangedHolders
Q1 2023500$520<0.1%−27,420−98.2%ReducedHolders
Q4 202227,920$23.2K<0.1%−28,572−50.6%ReducedHolders
Q3 202256,492$57.0K<0.1%+55,992+11,198.4%AddedHolders
Q2 2022500$1.00K<0.1%−4,765−90.5%ReducedHolders
Q1 20225,265$8.00K<0.1%−9,865−65.2%ReducedHolders
Q4 202115,130$30.0K<0.1%+14,630+2,926.0%AddedHolders
Q3 2021500$1.00K<0.1%−10,462−95.4%ReducedHolders
Q2 202110,962$21.0K<0.1%+10,462+2,092.4%AddedHolders
Q1 2021500$1.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.